PER® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
PER® is approved by the California Board of Registered Nursing, Provider #16669.
PER® maintains complete responsibility and control over all content, quality, and scientific integrity of its educational activities and plans, develops, implements, and evaluates them in accordance with the Accreditation Council for Continuing Medical Education (ACCME)’s Essential Areas and Elements, Policies and Standards for Commercial SupportSM, as well as guidelines set forth by the American Medical Association (AMA), California Board of Registered Nursing (CBRN), US Food and Drug Administration (FDA), US Department of Health and Human Services Office of Inspector General (OIG), Pharmaceutical Research and Manufacturers of America (PhRMA) and the Advanced Medical Technology Association (AdvaMed).
Disclosure PolicyIt is the policy of PER® to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities.
In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to start of each activity.
Participants are notified prior to the activity of any relationship or absence of a relationship between faculty and commercial interests. Information disclosed includes the name of the faculty, the nature of the affiliation or financial interest, and the name of the company/organization with which the relationship exists. Additionally, prior to the start of each activity PER® discloses the source of commercial support to the participants.
Permissions InformationPER® holds copyright to the content of its educational activities unless otherwise specified. No material may be reproduced in whole or in part, in any form, without written permission from the publisher or PER®.
Permission for reuse of PER® content in whole or in part may be obtained by contacting:
2 Clarke Drive, Suite 100
Cranbury, NJ 08512
Phone: (888) 949-0045 or (609) 378-3701
Fax: (609) 257-0705
To request permission, please describe the material you are interested in using by providing the following information:
- Author name(s), paper title, and publication title or title of educational activity.
- Describe how the material will be reused—e.g., in a presentation, in teaching material, or reprinted in a book or journal (include the publisher's name and the publication title).
- The specific amount of material to be reused—all of or portions of or only figures/tables from the publication. With respect to portions or figures, please describe the specific material.
- Date by which you need a response.
Our letter in response will grant permission. In most cases, the only requirement will be to give full credit to the original source. In cases involving the republication or sale of the material, a fee may also be required.
Please do not hesitate to write or call if you should have questions on this or any other copyright-related matters.
Feb 28, 2017
Cancer Summaries and Commentaries™: Updates from Singapore: Advances in Personalized Lung Cancer Treatment
Feb 28, 2017